240 related articles for article (PubMed ID: 12021516)
1. Oxidative stress and cardiovascular disease in dialyzed patients.
Usberti M; Gerardi GM; Gazzotti RM; Benedini S; Archetti S; Sugherini L; Valentini M; Tira P; Bufano G; Albertini A; Di Lorenzo D
Nephron; 2002 May; 91(1):25-33. PubMed ID: 12021516
[TBL] [Abstract][Full Text] [Related]
2. Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation.
Gerardi G; Usberti M; Martini G; Albertini A; Sugherini L; Pompella A; Di LD
Clin Chem Lab Med; 2002 Feb; 40(2):104-10. PubMed ID: 11939481
[TBL] [Abstract][Full Text] [Related]
3. Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis.
Zwołińska D; Grzeszczak W; Szczepańska M; Kiliś-Pstrusińska K; Szprynger K
Pediatr Nephrol; 2006 May; 21(5):705-10. PubMed ID: 16518626
[TBL] [Abstract][Full Text] [Related]
4. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
[TBL] [Abstract][Full Text] [Related]
6. Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end-stage renal failure.
Samouilidou E; Grapsa E
Blood Purif; 2003; 21(3):209-12. PubMed ID: 12784045
[TBL] [Abstract][Full Text] [Related]
7. Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure treated by hemodialysis.
Dirican M; Sarandol E; Serdar Z; Ocak N; Dilek K
Clin Nephrol; 2007 Sep; 68(3):144-50. PubMed ID: 17915616
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis.
Samouilidou EC; Grapsa EJ; Kakavas I; Lagouranis A; Agrogiannis B
Int Urol Nephrol; 2003; 35(3):393-7. PubMed ID: 15160547
[TBL] [Abstract][Full Text] [Related]
9. Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients.
Usberti M; Gerardi G; Micheli A; Tira P; Bufano G; Gaggia P; Movilli E; Cancarini GC; De Marinis S; D'Avolio G; Broccoli R; Manganoni A; Albertin A; Di Lorenzo D
J Nephrol; 2002; 15(5):558-64. PubMed ID: 12455724
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F; Floridi AG; Floridi A; Buoncristiani U
Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
[TBL] [Abstract][Full Text] [Related]
12. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
Islam KN; O'Byrne D; Devaraj S; Palmer B; Grundy SM; Jialal I
Atherosclerosis; 2000 May; 150(1):217-24. PubMed ID: 10781654
[TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen metabolites: a link between oxidative stress and inflammation in patients on hemodialysis.
Samouilidou E; Grapsa E; Karpouza A; Lagouranis A
Blood Purif; 2007; 25(2):175-8. PubMed ID: 17215574
[TBL] [Abstract][Full Text] [Related]
14. Accelerated atherosclerosis in haemodialysis patients; correlation of endothelial function with oxidative DNA damage.
Kaya Y; Ari E; Demir H; Soylemez N; Cebi A; Alp H; Bakan E; Gecit I; Asicioglu E; Beytur A
Nephrol Dial Transplant; 2012 Mar; 27(3):1164-9. PubMed ID: 21821836
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients.
Boaz M; Matas Z; Biro A; Katzir Z; Green M; Fainaru M; Smetana S
Am J Kidney Dis; 1999 Sep; 34(3):438-44. PubMed ID: 10469853
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum concentration of cardiotoxic lipid peroxidation products in chronic renal failure in relation to severity of renal anemia.
Siems W; Carluccio F; Grune T; Jakstadt M; Quast S; Hampl H; Sommerburg O
Clin Nephrol; 2002 Jul; 58 Suppl 1():S20-5. PubMed ID: 12227722
[TBL] [Abstract][Full Text] [Related]
17. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress.
Yang CC; Hsu SP; Wu MS; Hsu SM; Chien CT
Kidney Int; 2006 Feb; 69(4):706-14. PubMed ID: 16395251
[TBL] [Abstract][Full Text] [Related]
18. Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in haemodialysed patients?
Sommerburg O; Grune T; Hampl H; Riedel E; van Kuijk FJ; Ehrich JH; Siems WG
Nephrol Dial Transplant; 1998 Oct; 13(10):2583-7. PubMed ID: 9794564
[TBL] [Abstract][Full Text] [Related]
19. Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis.
Boaz M; Matas Z; Biro A; Katzir Z; Green M; Fainaru M; Smetana S
Kidney Int; 1999 Sep; 56(3):1078-83. PubMed ID: 10469377
[TBL] [Abstract][Full Text] [Related]
20. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
